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Background: Decline in verbal episodic memory is a core feature of amnestic mild cognitive impairment (aMCI).
The delayed story recall (DSR) test from the Adult Memory and Information Processing Battery (AMIPB) discriminates
MCI from normal aging and predicts its conversion to Alzheimer’s dementia. However, there is no study that
validates the Chinese version of the DSR and reports cut-off scores in the Chinese population.
Methods: A total of 631 subjects were screened in the memory clinics of Dongzhimen Hospital, Beijing University
of Chinese Medicine, China. 249 were considered to have normal cognition (NC), 134 met diagnostic criteria for MCI
according to the MCI Working Group of the European Consortium on Alzheimer's Disease, and 97 met criteria for
probable Alzheimer’s disease (AD) according to the NINCDS/ADRDA criteria, 14 exhibited vascular dementia (VaD),
and 50 had a diagnosis of another type of dementia. Receiver operating characteristic (ROC) curve analyses were
used to calculate the story recall cutoff score for detecting MCI and AD. Normative data in the NC group were
obtained as a function of age and education.
Results: In this Chinese sample, the normative mean DSR score was 28.10 ± 8.54 in the 50–64 year-old group,
26.22 ± 8.38 in the 65–74 year-old group, and 24.42 ± 8.38 in the 75–85 year-old group. DSR performance was
influenced by age and education. The DSR test had high sensitivity (0.899) and specificity (0.799) in the detection of
MCI from NC using a cut-off score of 15.5. When the cutoff score was 10.5, the DSR test obtained optimal sensitivity
(0.980) and specificity (0.938) in the discrimination of AD from NC. Cutoff scores and diagnostic values were calculated
stratified by age and education.
Conclusions: The Chinese version of the DSR can be used as a screening tool to detect MCI and AD with high
sensitivity and specificity, and it could be used to identify people at high risk of cognitive impairment.
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Mild cognitive impairment (MCI), a diagnosis given to
individuals who have memory or slight cognitive impair-
ments but do not meet the criteria for dementia, is a
transitional stage between normal aging and dementia [1].
The prevalence of MCI ranges from 16% to around 31%
in elderly people (older than 65 years), with approximately* Correspondence: jztian@hotmail.com
†Equal contributors
1The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University
of Chinese Medicine, Beijing 100700, China
Full list of author information is available at the end of the article
© 2014 Shi et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.15% of people with MCI converting to Alzheimer’s disease
(AD) within one year, 34% within two years, and 57% in
3 years [2]. Among different types of MCI, amnestic MCI
is recognized to progress preferentially to AD, and is rec-
ognized as a possible prodromal stage of AD [3]. Studies
have shown that 5.9% of people aged 65 years and above
in China have AD, at present China has 6 million patients
with dementia and, with a rapidly ageing population [4], it
is estimated to have 1 million new cases every year [5].
However, an international team of researchers has found
that over 93.1% of dementia cases in China go undetected,
with a high level of undiagnosed dementia in rural areas. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sessment instruments applicable to the Chinese language
and culture.
In the detection of MCI, verbal episodic memory per-
formance is generally considered as the best predictor of
cognitive decline [7]. Previous studies have shown that
episodic memory tests such as paragraph recall are sensi-
tive to MCI and very early cognitive impairment in older
adults [8]. Delayed story recall performance can not only
significantly predict progression from MCI to AD [9,10],
but also has high sensitivity and specificity for the early
diagnosis of AD, and can discriminate very mild/early
stage AD and non-demented elderly effectively [11]. De-
layed memory testing and recall-based assessments have
been identified as the most discriminating factors in
those individuals at risk of progression to AD [12]. To
date, there is no consensus on the optimal neuropsycho-
logical assessment tool to assess episodic memory in MCI.
The Adult Memory and Information Processing Battery
[AMIPB] [13] is a tool that was designed to assess immedi-
ate registration of verbal information and retention over
time. It contains six sub-tests: two verbal memory tests
(one of which is a story recall), two visual memory tests
and two information-processing tests. The story recall test
includes immediate story recall (ISR) and delayed story re-
call (DSR), and is similar in structure to the Wechsler
Memory Scale (WMS) logical memory test [14]. Previous
studies have shown that the story recall test is the stron-
gest predictor of reported memory performance in daily
life by elderly adults [15,16]. The advantages of the AMIPB
story recall test is that it has detailed administration and
scoring instructions, and normative data ranging from 18
to 75 years old.
However, most studies have been conducted in the set-
ting of a Western culture. There is no Chinese version nor
any studies using the story recall test in China. Moreover,
cut-off scores for the Chinese population are not known.
Hence, it is important to validate the subtests in the con-
text of the Chinese culture and language, and develop ap-
propriate cut-off points for the Chinese population.
This study aims to evaluate the sensitivity and specificity
of the Chinese version of the delayed story recall test, and
to determine the optimal cutoff score for a clinical diagno-
sis of amnestic MCI or AD in the Chinese population.
Methods
The Chinese version of the story recall
The story from the AMIPB, which is about a woman and
a thief, was translated into Chinese using back translation
methods. The original English version was translated by
clinical psychologists, one bilingual, and all with an ex-
cellent command of English; the translations were then
handed to two specialists in neuropsychology, and two
psychiatrists for their revision; they discussed and revisedthe first version translations; back translations were then
made from Chinese into English by a bilingual psycholo-
gist; finally, a final Chinese version was made by clinical
neuropsychology and psychiatry professionals.
The Chinese version represents a literal translation of
the original English version, with the exception of the
following modifications: We replaced the name ‘Angela/
Harper’ with the Chinese name ’Shuzhen Wang (王淑珍)’.
Participants
Chinese-speaking adults, aged 50 to 85 years old, with
memory complaints, were screened between January 2007
and April 2011 in the memory clinic of Dongzhimen Hos-
pital of Beijing University of Chinese Medicine, China.
All participants underwent a clinical and neuro-
psychological evaluation, involving the following assess-
ment instruments: the Mini-mental state examination
(MMSE) [17], Activities of Daily Living (ADL) [18] scale,
the Hachinski Ischemia scale (HIS) [19], the Hamilton
Depression Scale (HAMD) [20], the Adult Memory and
Information Processing Battery (AMIPB) story recall [13],
and the Clinical Dementia Rating (CDR) [21] score. The
allocation of patients to different groups was based on re-
sults of the mental state examination, neuropsychological
assessment, laboratory results and neuroimaging.
Normal control (NC) subjects were identified in accord-
ance with criteria used in the Mayo research study [22]: (1)
no active neurological or psychiatric disease, (2) no psycho-
tropic medication, (3) no medical disorder for which the
disorder or its treatment could compromise cognitive func-
tion, an MMSE score >26 point (for people attaining
higher education), MMSE>23 (middle school), MMSE>22
(primary school), MMSE>19 (Illiteracy), scores based on a
previous study of the Chinese population [17,23], CDR
[21] score = 0;(4) fully independent abilities in activities of
daily living (ADL<16) [18].
MCI subjects were required to meet diagnostic criteria
for MCI documented by the MCI Working Group of the
European Consortium on Alzheimer's Disease [24]. The
following were adopted as operational criteria (Chinese
version) for inclusion into the MCI group for the present
study at screening [23]: (1) cognitive complaints from the
patients or their families; (2) report of a relative decline in
cognitive functioning during the past year by the patient or
informant; (3) normal general cognitive function, as deter-
mined by a clinician's judgment based on a structured inter-
view with the patients: MMSE scores in the normal control
ranges; (4) cognitive disorders as evidenced by clinical eval-
uation, CDR [21] score = 0.5, memory domain = 0.5; (5)
preservation of activities of daily living, ADL score <16 [18];
(6) absence of dementia, not sufficiently impaired, cogni-
tively and functionally, to meet NINCDS-ADRDA criteria
for AD [25], as judged by an experienced dementia research
clinician. (7) In addition, they were judged to have a
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HIS [19], and no or minimal medial temporal atrophy
(MTA) or hippocampal volume atrophy on an MRI
scan. The latter was assessed using the medial temporal
lobe atrophy (MTA) scale, the most widely published
visual rating scale. Ratings were made by three clinicians
who were blinded to diagnosis and age of the subjects, and
a definitive score was assigned through consensus [23].
Exclusion criteria were: (1) meeting criteria for demen-
tia; (2) depression or psychosis of juvenile onset; (3)
other neural system diseases including Parkinson's dis-
ease, or other cerebral pathology as verified by a formal
clinical examination.
The diagnosis of dementia was based on the Diagnostic
and Statistical Manual of Mental disorders, fourth edition
(DSM-IV) [26], and the diagnosis of Alzheimer’s disease
was in accordance with the National Institute of Neuro-
logical Communicative Disease and Stroke (NINCDS) and
Alzheimer's Disease and Related Disorders Association
(ADRDA) criteria for probable AD [25]. A diagnosis of AD
was based on clinical and neuropsychological assessments:,
MMSE scores fall below the normal, education-appropriate
cutoffs; (2) two or multiple domain cognitive impairment,
CDR ≥ 0.5; (3) progressive deterioration of memory and
other cognitive functions; (4) no disturbance of con-
sciousness; (5) impairment in activities of daily living,
ADL score ≥16; (6) absence of cerebrovascular disease,
HIS score ≤4; (7) and medial MTA or hippocampal atro-
phy on MR imaging; (8) exclusion of other disease which
may cause cognitive impairment.
AD exclusion criteria were: (1) acute onset; (2) focal
nervous system signs in early stage disease, for example,
incomplete paralysis, anesthesia, visual field defect, and
ataxia; (3) epileptic attack or gait disturbance in early
stage of disease; (4) depression or other mental disor-
ders, HAMD>12 (17 items).
The operationalized criteria for inclusion of amnestic
MCI and AD have been reported previously [27]. The
diagnostic flow chart is shown in Figure 1.
Procedures
The clinical assessments, laboratory investigations, mea-
surements of vital signs (including temperature, blood
pressure and electrocardiogram), neurological tests (includ-
ing an examination of cranial nerves, motor coordination,
muscle power and tone) and neuroimaging were carried
out before the patients were enrolled in the study. Before
initiation of the project, 6 physicians participated in training
in standard administration of the DSR. The participating
physicians were instructed to administer the DSR consistent
with the original guidelines of the AMIPB, outlined below.
A short story is read to the patient, who is then asked
to immediately recall it. Patients are allowed up to 2 mi-
nutes to recall the story and are allocated a score of 0, 1or 2 depending on the accuracy of their recall. Under
the AMIPB scoring scheme, any correctly recalled idea
(or an accurate paraphrase thereof ) is awarded two
points, and any vaguely or partially recalled ideas receive
one point. Detailed guidelines with examples of scoring
are also given in the AMIPB. The story contains 28
ideas. Therefore the maximum possible score is 56. After
23–30 minutes the patient is asked to recall the same
story; the same scoring system is applied.
The psychiatric and neurological classifications were
made blind to subjects’ story recall performance. The
story recall test score had no impact on diagnostic clas-
sifications of AD, MCI or NC.
The protocol was approved by Dongzhimen Hospital,
Beijing University of Chinese Medicine Institutional
Ethics Committee. The study was undertaken in accord-
ance with the principles of the Declaration of Helsinki.
The patients and responsible caregivers provided written
informed consent.
Statistical methods
SPSS 17.0 for Windows was used for the data analyses.
Sex distributions in the 3 groups were compared using
the chi-square test, mean age, education years, MMSE
scores and DSR were compared by nonparametric tests.
Partial correlations were determined between the MMSE
and DSR by controlling for age and education. Receiver
operating characteristic (ROC) curve analyses allowed
calculation of the optimal sensitivity (to correctly detect
cases) and optimal specificity (to correctly detect controls)
using different cut-off scores of the DSR. The positive pre-
dictive values (ppv) and negative predicative (NPV) values
were measures at the threshold scores. A proportion of the
study cohort was re-assessed 3 months after the initial test,
and bivariate correlation analysis was applied to evaluate
retest reliability of the DSR. P values below 0.05 were con-
sidered statistically significant throughout the analysis.
A previous study has shown that DSR performance was
influenced by age and education. Accordingly, we attempted
to develop a statistical correction for effects of age and
education and test the efficacy of the statistically adjusted
DSR as a screening test for detecting NC, MCI, AD and
dementia.
The following steps were taken to convert raw scores
to T scores: (1) multiple regression based norms were
constructed using the normal cognition group; (2) using
the weights (beta’s) from the same regression analysis,
expected scores for each patient were calculated using
the formula (expected value = 31.535 + 0.746 × years of
education-0.206 × age); (3) the residual of each case was
calculated using the raw score minus expected score; (4)
the standardized residuals (Z values) was calculated using
the residuals/residual Std.Deviation; (5) the standardized
residuals (Z values) was converted to T scores according
Figure 1 Diagnostic algorithm for Alzheimer’s disease, amnestic MCI, and normal cognition. Notes: AD = Alzheimer’s disease; aMCI = amnestic
mild cognitive impairment; CDR = clinical dementia rating scale; MMSE =Mini-mental State Examination; NC = normal cognition; ADL = Activities of
Daily Living; HIS = Hachinski Ischemia scale; HAMD=Hamilton Depression Scale.
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ROC analyses allowed calculation of the optimal sensitiv-
ity and optimal specificity using different cut-off scores of
the adjusted scores (T scores).
Results
Demographic and neuropsychological variables
A total of 631 subjects were enrolled. Three patients were
excluded because they did not complete the neuropsycho-
logical assessment, 71 were diagnosed with depression, 14
were considered as having vascular cognitive impairment
(VCI), 14 exhibited vascular dementia(VaD), and 50 had a
diagnosis of other types of dementia. 249 were classified
as NC, 134 as MCI, and 97 as AD. The “All types of de-
mentia group” includes the AD (n = 97), VaD (n = 14), and
mixed dementia (n = 50) groups. The study subjects flow
chart was shown in Figure 2.
The characteristics of the NC, MCI, AD and all types
of dementia groups can be seen in Table 1. There were
significant group differences in age and education. The
AD and all type of dementia group were significantly older
than the MCI group (P = 0.000), and had fewer years of
education (P = 0.000). In addition, the MCI group was sig-
nificantly older than the NC group (P = 0.000) and had
fewer years of education (P = 0.000).
MMSE, DSR and ISR scores in the AD group and all
type of dementia group were significantly lower than in theNC group and MCI group (P = 0.000, P = 0.000, P = 0.000),
and those of the MCI group were significantly lower than
in the NC group (P = 0.000, P = 0.000, P = 0.000). There
was no significant difference between the four groups in
terms of sex, race, history of smoking and drinking, and
family history of dementia. There was no difference be-
tween the four groups regarding concomitant diseases, ex-
pect hyperlipidemia and stroke.
Using data from the patients who underwent neuro-
psychological assessments we entered age and education
and HAMD scores into a multiple linear regression analysis
with DSR score as the dependent variable. This model over-
all was statistically significant (F = 12.338, P = 0.000), and
can account for 13.3% of the total DSR scores. Examination
of the sum of squares for each term in the model, showed
that age contributed to the models, and the standardized
coefficients were −0.206(P = 0.001). Years of education
also had a significant impact on the DSR score (r = 0.746,
P = 0.000).Normative data as a function of age and education
Given the significant effect of age and education on story
recall performance, the present normal control sample’s
performance was divided into three age-groups: 50–
64 years, 65–74 years and 75–85 years and these are
presented in Table 2.
Figure 2 Standard study flow chart. Notes: MCI = Mild cognitive impairment; VCI = Vascular cognitive impairment.
Table 1 Demographic and neuropsychological characteristics of participant groups
Group NC n = 249 MCI n = 134 AD n = 97 All type of dementia n = 161 X2 P
Age 66.94 ± 8.87 69.91 ± 8.38** 71.09 ± 9.04**▲▲ 70.93(9.15)** 20.052 0.000
Education 12.89 ± 3.30 11.32 ± 3.84** 10.63 ± 4.49**▲▲ 10.55(4.39)** 23.622 0.000
MMSE 28.41 ± 1.50 26.98 ± 2.04** 15.69 ± 5.91**▲▲ 16.28 (6.06)**△△ 255.721 0.000
HAMD 3.78 (3.30) 3.84 (3.12) 2.42 (2.12) 2.78 (2.47) 17.484 0.001
Sex (Male/Female) 158/91 76/58 54/43 81/80 2.597 0.273
Race (Han/Others) 238/11 127/6 92/4 153/7 0.016 0.993
Concomitant diseases
Hypertension 107 62 30 63 5.727 0.126
Hyperlipidemia 93 33 8 21 46.632 0.000
Diabetes 53 21 14 30 2.828 0.419
Stroke 57 36 13 65 26.287 0.000
History of smoking 45 26 12 39 5.681 0.128
History of drinking 30 19 11 29 3.543 0.315
Family history of dementia 42 27 20 29 1.105 0.776
Story recall test
ISR 30.03 ± 8.58 13.91 ± 8.79** 4.02 ± 6.06**▲▲ 4.49 ± 5.964**▲▲ 440.559 0.000
DSR 26.60 ± 8.49 9.40 ± 8.88** 1.60 ± 4.58**▲▲ 1.63 ± 4.315**▲▲ 460.195 0.000
Notes: Means ± SD was presented except for sex. **P ≤ 0.01 MCI/AD vs NC; ▲▲P ≤ 0.01 MCI vs AD.
NC = normal cognition; MCI = mild cognitive impairment. AD = Alzheimer’s disease. MMSE =Mini-mental State Examination; DSR = Delayed story recall;
ISR = Immediate story recall; HAMD = Hamilton depression rating scale.
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and all type of dementia) from NC
We calculated the sensitivity and specificity of ISR and
DSR for distinguishing subjects with cognitive impairment
(MCI and all types of dementia groups) from the NC
group (Figure 3). The area under the curve (AUC) was
0.960 (P = 0.000) (95% confidence intervals(CI):0.946 ~
0.974) for DSR and 0.954 (95% CI: 0.940 ~ 0.969) for ISR.
When the cutoff score was 12.5 for DSR, an optimal
balance was obtained between the sensitivity and specificity
(95.2% and 88.8%, respectively) in distinguishing cognitive
impairment and NC.Figure 3 Receiver operating characteristic curve of story recall
in the differentiation of cognitive impairment (mild cognitive
impairment and all type of dementia) from normal cognition.
Notes: ISR = Immediate story recall; DSR = Delayed story recall.Story recall discrimination of MCI from NC
MCI, especially, aMCI is generally recognized to represent
the early-stage of dementia. Hence, we compared subjects
with normal cognition with those diagnosed with MCI.
The ROC curves were produced by plotting the sensitivity
against the 1-specificity for each score on the DSR and
ISR for MCI cases versus NC. The area of curve (AUC) of
ISR and DSR was 0.898 (95% CI: 0.865 ~ 0.930) and 0.908
(95% CI: 0.875 ~ 0.941) respectively. When the cutoff score
was 15.5, the DSR obtained optimal sensitivity and specifi-
city (0.899 and 0.799) for discriminating MCI from NC
(Figure 4).Table 2 Normative data for story recall stratified by age and
Age 50-64
Education (years) ≤9 (n = 23)
Mean ± SD Percentiles
5th 10th
ISR 29.04 ± 9.70 8 20
DSR 24.48 ± 8.94 3.75 16.0
Percentage story retained (DSR/ISR × 100%) 81.47%
Age 65
Education (years) ≤9 (n = 22)
Mean ± SD Percentiles
5th 10th
ISR 28.41 ± 10.98 7.35 15.6
DSR 23.91 ± 9.14 10.0 10.6
Percentage story retained (DSR/ISR × 100%) 87.32%
Age 75
Education (years) ≤9 (n = 12)
Mean ± SD Percentiles
5th 10th
ISR 25.17 ± 7.58 13.0 13.6
DSR 22.58 ± 7.79 11.0 12.2
Percentage story retained (DSR/ISR × 100%) 82.59%
Note: ISR = Immediate story recall; DSR = Delayed story recall.As DSR scores were impacted by age and education,
cutoff scores on the DSR were calculated stratified by
age and education. The cutoff scores and diagnostic
values are shown in Table 3.education
>9 (n = 54) Total subjects (n = 77)
Mean ± SD Percentiles Mean ± SD Percentiles
5th 10th 5th 10th
33.04 ± 8.31 16.0 19.0 31.18 ± 8.89 16.2 20.0
30.46 ± 7.99 13.0 18.0 28.10 ± 8.54 13.4 18.0
92.79% 90.07%
-74
>9 (n = 47) Total subjects (n = 69)
Mean ± SD Percentiles Mean ± SD Percentiles
5th 10th 5th 10th
31.47 ± 7.33 19.0 21.0 30.16 ± 8.43 17.75 19.5
28.43 ± 7.12 13.0 16.0 26.22 ± 8.92 12.0 15.0
90.73% 87.37%
-85
>9 (n = 27) Total subjects (n = 39)
Mean ± SD Percentiles Mean ± SD Percentiles
5th 10th 5th 10th
29.19 ± 7.05 13.7 15.8 27.75 ± 7.95 13.5 15.0
25.37 ± 8.26 10.5 12.8 24.42 ± 8.90 11.0 13.0
85.79% 85.90%
Figure 4 Receiver operating characteristic curve of story recall in
the differentiation of mild cognitive impairment from normal
cognition. Notes: ISR = Immediate story recall; DSR =Delayed story recall.
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We compared NC subjects with those diagnosed with
AD by a ROC curve. The AUC was 0.986 (0.974 ~ 0.999)
for the DSR for detecting AD and 0.988 (95% CI: 0.978
~ 0.998) for detecting all type of dementia. And 0.988
(95% CI: 0.970-0.998) for ISR for detecting AD and
0.984 (0.972 ~ 0.996) for detecting all type of dementia. A
DSR cutoff score of 10.5 yielded an optimal sensitivity
and specificity of 0.980 and 0.938 respectively for dis-
criminating AD and NC. The discrimination between
NC and AD stratified by age and education was also cal-
culated, as shown in Table 3.
Based on our formula, we calculated the sensitivity
and specificity of the adjusted scores (T scores). When
the adjusted score was 36.4874, an optimal sensitivity ofTable 3 Cutoff scores and diagnostic value of the DSR for dis
MCI
DSR cutoff Sensitivity Speci
Mean 15.5 0.899 0.7
Age 50-64 15.5 0.922 0.7
Education ≤9 15.5 0.917 0.8
Education >9 17.5 0.886 0.7
Age 65-74 12.5 0.947 0.8
Education ≤9 10.5 1.000 0.9
Education >9 13.0 0.909 1.0
Age >75 10 0.980 0.5
Education ≤9 8.5 0.730 0.8
Education >9 10.5 1.000 0.9
Note: AD = Alzheimer’s Disease; DSR = Delayed story recall; MCI = Mild cognitive imp0.894 and specificity 0.775 was obtained to discriminate
NC from MCI. When the cutoff score was 36.6669, the
sensitivity (0.955) and specificity (0.864) was obtained to
screening all type of dementia from NC group.
Based on this sample, the prevalence of MCI was 21.2%,
and the prevalence of AD was 14.9%. The PPV and NPV
was 0.72 and 0.99 respectively for the detection of AD, the
PPV and NPV was 0.57 and 0.96 respectively for the de-
tection of MCI. The sensitivity, specificity, PPV and NPV
of DSR for different prevalence rates of AD and MCI are
shown in Table 4.Partial correlation between MMSE and DSR
Given that age and education impact on DSR, we calcu-
lated the correlation between MMSE and DSR, control-
ling for age and education. DSR scores were significantly
correlated with MMSE scores (r = 0.575, P = 0.000).Test -retest reliability of DSR
56 MCI patients were re-assessed 3 months from baseline,
using the same neuropsychological tests. Re-test reliability
was calculated by analyzing the correlation between base-
line and 3-month scores. The DSR showed high retest re-
liability (r = 0.887, P = 0.011). The higher the correlation
between two evaluations the greater the reliability of the
test in the diagnosis of MCI.Discussion
To date, there has been a lack of validation studies of story
recall measures conducted in a Chinese population. This
study provides evidence that story recall has good sensitiv-
ity and specificity in discriminating MCI from normal cog-
nition and from AD. This finding provides further evidence
that episodic memory declines at an early stage of AD.
The only difference between the original English and
Chinese version of the story recall test was a change ofcriminating AD and MCI
AD
ficity DSR cutoff Sensitivity Specificity
99 10.5 0.980 0.938
14 12.5 0.973 0.960
98 5.50 1.000 0.917
14 13.50 .958 1.000
15 9.5 0.979 0.900
45 5.0 1.000 1.000
00 10.5 0.970 0.882
85 5.0 1.000 0.900
06 3.5 1.000 0.905
04 9.5 0.973 0.974
airment.
Table 4 Sensitivity and specificity of DSR in the discrimination of Alzheimer’s disease and mild cognitive impairment
and positive predictive values (PPV) and negative predictive values (NPV) at different base rates
Alzheimer’s disease PPV/NPV at different base rate
DSR cutoff Sensitivity Specificity 10% 20%% 30% 40% 50%
6.50 0.992 0.907 0.54/1.00 0.73/1.00 0.60/1.00 0.64/0.99 0.68/0.99
7.50 0.988 0.907 0.54/1.00 0.73/1.00 0.82/0.99 0.88/0.99 0.91/0.99
9.00 0.988 0.918 0.57/1.00 0.75/1.00 0.84/0.99 0.89/0.99 0.92/0.99
*10.50 0.980 0.938 0.63/1.00 0.80/1.00 0.87/0.99 0.91/0.98 0.94/0.98
11.50 0.972 0.938 0.63/1.00 0.80/1.00 0.87/0.99 0.91/0.98 0.94/0.97
12.50 0.952 0.959 0.72/1.00 0.85/0.99 0.91/0.98 0.94/0.97 0.96/0.95
14.00 0.923 0.969 0.77’0.99 0.88/0.98 0.93/0.97 0.95/0.95 0.97/0.93
Mild cognitive impairment PPV/NPV at different base rate
DSR cutoff Sensitivity Specificity 10% 20% 30% 40% 50%
12.50 0.952 0.739 0.29/0.99 0.48/0.98 0.60/0.97 0.71/0.96 0.78/0.94
14.00 0.923 0.761 0.30/0.99 0.49/0.98 0.62/0.96 0.72/0.94 0.79/0.91
*15.50 0.899 0.799 0.33/0.99 0.53/0.97 0.66/0.95 0.75/0.92 0.82/0.89
16.50 0.879 0.821 0.35/0.98 0.55/0.96 0.68/0.94 0.77/0.91 0.83/0.87
17.50 0.855 0.821 0.35/0.98 0.54/0.96 0.67/0.93 0.76/0.89 0.83/0.85
18.50 0.819 0.836 0.36/0.98 0.56/0.95 0.68/0.92 0.77/0.87 0.83/0.82
19.50 0.782 0.843 0.36/0.97 0.55/0.94 068/0.90 0.77/0.85 0.83/0.79
Note: *indicates the cutoff with optimal sensitivity and specificity.
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most popular names in Chinese.
Multiple linear regression analysis was used in this
study, and the results showed that age and education
contributed to the DSR total score. Age showed a negative
correlation whereas education level showed a positive cor-
relation with DSR scores. These findings are consistent
with those of the original version of the AMIPB story re-
call test: it was noted that scores on the DSR should be
adjusted for age and education.
In the present study, we calculated the sensitivity and
specificity of DSR to discriminate MCI or AD from NC.
The DSR had a high sensitivity (0.899) and specificity
(0.799) in the detection of MCI from NC when the cut-
off score was 15.5, and when the cutoff score was 10.5,
the DSR obtained optimal sensitivity (0.980) and specifi-
city (0.938) in the discrimination AD from NC.
The MMSE has, for many years, been widely used to
assess global cognition in clinical settings. A meta-analysis
showed that the MMSE had a poor sensitivity of 85.1%,
specificity of 85.5%, PPV of 34.5% and NPV of 98.5% in
the distinction between AD and NC. But, it had very lim-
ited value in making a diagnosis of MCI against healthy
controls with modest rule-out accuracy. It had similarly
limited ability to distinguish cases of AD from MCI [28].
Hence, the DSR may be more suitable in the detection of
MCI or AD compared to the MMSE.
We have provided age and education adjusted norma-
tive data for the DSR in this sample. The original versionof the test also provided normative data, for an 18 to
75 year old age range. The normative data of the English
version were stratified into four age groups: 18–30 years
old, 31–45 years old, 46-60 years old, and 61–75 years
old. The mean score was 34.1 ± 10.9 in the 46–60 year
old group, and 30.7 ± 11.1 in the 61–75 year old group.
In this Chinese sample, the total subject cohort was di-
vided into a 50–64 year old group, 65–74 year old group
and 75–85 year old group, and each of those groups was
further divided according to education. In this Chinese
sample, the normative data are 28.10 ± 8.54 in the 50–
64 year old group, 26.22 ± 8.92 in the 65–74 year old
group, and 24.42 ± 8.90 in the 75–85 year old group.
Owing to the different age banding, the normative data
are not directly comparable for the English and Chinese
versions. Nevertheless, these normative data presented
for a sample of the Chinese population, stratified accord-
ing to age and education ought to be valuable for the
memory assessment of clinical conditions including mild
cognitive impairment and AD.
According to the MCI criteria, as defined by Petersen,
MCI was classified as (1) amnestic MCI(aMCI), which is
said to progress preferentially to AD; (2) MCI character-
ized by slight impairment in multiple cognitive domains
(‘multiple‐domain slightly impaired’), which may pro-
gress to AD, to VaD, or may even represent a cognitive
ageing process that qualifies as normal; and (3) MCI cor-
responding to an isolated impairment in a single cogni-
tive domain other than memory (‘single‐domain non‐
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dementia [29,30]. The diagnosis of a MCI was based on
memory tests 1.5 standard deviation (SD) below normative
values. However, the Petersen criteria did not supply nor-
mative values, so that the diagnosis of a MCI remains diffi-
cult in clinics. This study supplied normative data for a
Chinese population. Using the Petersen MCI criteria for-
mula (cutoff score = norm-1.5SD), the DSR cutoff score
would be 15.3 points for the 50–64 year old group, 12.84
points for the 65–74 year old group, 11.0 points for the
75–85 year old group. These cutoff scores was consen-
sus to those calculated by the ROC curve. In this sample,
the cutoff socre was 15.5 for 50–64 year old group, and
12.5 for the 65–74 year old group, and 10 for the 75–85
group in to detecting MCI from NC.
One of the important issues is the predictive value of
the DSR. The DSR showed a satisfactory PPV and NPV
in this sample. The PPV and NPV were calculated with a
cutoff score of 15.5 points for distinguishing MCI from
NC. Because the PPV and NPV can be influenced by the
base rate of the disease, they were calculated based on
literature reports that the prevalence of MCI varies greatly
from one study to another, ranging from 3% to around
17% of elderly people (>65 years) [31]. Based on a preva-
lence of 3%, the PPV and NPV were 12.1% and 99.6% re-
spectively for DSR in detecting MCI, 47.8% and 97.5% for
detecting MCI based on a prevalence of 17%, and 82%
and 85% based on a prevalence of 50%. The lower the base
rate the lower is the PPV. The NPVs are very high, sug-
gesting that we can reassure with confidence those per-
sons who have negative results on these assessments, and
they may avoid further neuropsychological evaluations.
The calculation of PPV and NPV indicates that the DSR is
most valuable in the assessment of people at high risk of
cognitive impairment.
In this study, multiple regression showed that age and
education were related to the DSR score, so we attempted
to develop a model that yielded age and education ad-
justed norms. Using this model we converted the raw
score to adjusted score, and a ROC curve was calculated
using the adjusted score. This model effectively adjusts for
the effects of age and education. However, it may be diffi-
cult to apply it in clinical screening, since it would be in-
convenient to calculate adjusted scores for every subject.
Finally, it must be pointed out that the diagnosis of de-
mentia and MCI is a clinical one. It must be based on the
clinical interview, neurological examination, laboratory re-
sults and imaging, as well as neuropsychological test data.
The DSR can only be used as a screening tool, not a diag-
nostic tool.
There are several limitations in this study, including
the relatively small sample size of patients, and a short
period of follow-up. Moreover, all subjects were enrolled
from a memory clinic, and all, including those who provedto be cognitively normal, had subjective cognitive com-
plaint. Hence, the subjects identified as normal control
subjects may not be representative of the normal healthy
population, subtle abnormalities may have gone un-
detected, and resulted in a slight reduction in the obtained
normative values. Sensitivity may increase if normative
data are obtained from healthy controls from within the
general population.
Hence, further studies should be conducted on a larger
scale, with longer-term follow-up, and using population-
based healthy controls, in order to evaluate the predict-
ive value of the DSR.
Conclusion
The DSR can be used as a screening tool to detect MCI
and AD with high sensitivity and specificity. The DSR cor-
relates with MMSE, and shows high test-retest reliability.
The current data show that it is a sensitive screening tool
for detecting MCI and AD in the Chinese population. The
influence of age and education should be considered in
the use of this tool. Additionally, due to the low positive
predictive value in people with a low incidence of cogni-
tive impairment, it could be used to identify people with a
high risk of cognitive impairment.
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